Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MILESTONE SCIENTIFIC INC.MLSS · Entity 7313 | Director | August 28, 2024 | August 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MILESTONE SCIENTIFIC INC.
Report date August 28, 2024 · Filed August 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $0.001SEC Table I · non-derivative | Direct | 10,418,382 |
Reported balance
After 2024-08-28 transaction · row 1
1 source rowRow 1 · 2024-08-28 · Grant · Acquired 112,356 · Balance 10,418,382 F1: Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2024, January 1, 2025, and April 1, 2025 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2024, January 1, 2025, and April 1, 2025
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2017 Filed Jul 11, 2017 21:29 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantOptions to purchase common stock · Derivative | 250,000 | Not disclosed Strike: $2.55 | Not disclosed |
DisclosureSEC source: 0001437749-17-012482 · rdgdoc.xml · derivative · entry 3 Trombetta Giandomenico · CIK 0001606650 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2019-12-21 F1 · price: Not applicable. Read SEC document |
| January 25, 2017 Filed Feb 2, 2017 23:01 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantOptions to purchase common stock · Derivative | 99,378 | Not disclosed Strike: $1.61 | Not disclosed |
DisclosureSEC source: 0001437749-17-001562 · rdgdoc.xml · derivative · entry 3 Trombetta Giandomenico · CIK 0001606650 · Director · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,378 Underlying: Common Stock · 99,378 shares Expires 2022-01-25 F1 · price: Not applicable. F6 · derivative.exercise_date: These options are exercisable as follows: (i) for 33,126 shares on the date of grant (1-25-17) and (ii) for an additional 1/3 of the 66,252 remaining shares on each of the 1st through 3rd anniversaries of the date of grant. Read SEC document |
| January 25, 2017 Filed Feb 2, 2017 23:01 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantCommon Stock, Par Value $0.001 | 49,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-001562 · rdgdoc.xml · nonDerivative · entry 1 Trombetta Giandomenico · CIK 0001606650 · Director · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,079 F1 · price: Not applicable. F5 · balance_after: All of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.